13 results found.

Venous Thrombosis Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939)

Bayer - Recruiting 18 years or older.
- Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto® Following an Acute Deep Vein Thrombosis (DVT).
Rivaroxaban (Xarelto, BAY59-7939)

Deep Vein Thrombosis Clinical Trial using Thrombectomy

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation.
Thrombectomy

Deep Vein Thrombosis, or Venous Thrombosis Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939); Standard of care

Bayer - Recruiting 18 years or older.
- Xareltor for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE).
Rivaroxaban (Xarelto, BAY59-7939); Standard of care

Deep Vein Thrombosis, Venous Thrombosis, Postphlebitic Syndrome, Clinical Trial using Recombinant tissue plasminogen activator (rt-PA)

Washington University School of Medicine - Recruiting 16 years to 75 years.
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial.
Recombinant tissue plasminogen activator (rt-PA)

Achilles Tendon Rupture, or Deep Vein Thrombosis Clinical Trial using Controlled early mobilization

Hvidovre University Hospital - Recruiting 18 years to 70 years.
- Non-operative Treatment of Acute Achilles Tendon Rupture, Early Controlled Mobilization Compared With Immobilization: A Blinded Randomized, Controlled Trial.
Controlled early mobilization

Deep Vein Thrombosis (DVT), or Pulmonary Embolism Clinical Trial using Bemiparin

Hawler Medical University - Recruiting 25 years to 90 years.
- Bemiparin as a Thromboprophylaxis After Benign Gynaecological Surgeries:A Randomized Clinical Trial.
Bemiparin

Deep Vein Thrombosis Clinical Trial

Indiana University - Recruiting 1 Month to 12 years.
- Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures.

Heart Attack, Cardiac Arrest, Congestive Heart Failure, Atrial Fi Clinical Trial

Washington University School of Medicine - Recruiting 18 years or older.
- SATISFY-SOS: Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys.

Deep Vein Thrombosis, or Pulmonary Embolism Clinical Trial using Rosuvastatin

Leiden University Medical Center - Recruiting 18 years or older.
- Prospective Randomized Controlled, Open Label, Clinical Trial to Study if Rosuvastatin Use Improves the Coagulation Profile in Patients With Venous Thrombosis.
Rosuvastatin

Atrial Fibrillation, Deep Vein Thrombosis, Cardiac Valvular Insuf Clinical Trial

University of Puerto Rico - Recruiting 18 years to 90 years.
- Pharmacogenetics of Warfarin in Puerto Rican Patients Using a Physiogenomics Approach..

Medical Patient, or Thrombocytopenia Clinical Trial using Fondaparinux

G. d'Annunzio University - Recruiting 18 years or older.
- Thromboprophylaxis With Fondaparinux of Deep Vein Thrombosis and Pulmonary Embolism in the Acutely-ill Medical Inpatients With Thrombocytopenia.
Fondaparinux

Deep Vein Thrombosis Leg, or Stroke (in Patients With Atrial Fibr Clinical Trial using DPOC-4088; Placebo

Diakron Pharmaceuticals - Recruiting 18 years to 50 years.
- A Randomized, Double-blind, Placebo-controlled, Stepwise Study of the Pharmacokinetics (PK), Pharmacodynamics (PD), PK/PD Characteristics and Safety of Multiple Once-daily Oral Dosing of DPOC-4088 in Healthy Young Male Subjects.
DPOC-4088; Placebo

Deep Vein Thrombosis, or Cancer Clinical Trial using low molecular weight heparin

Azienda Ospedaliera Universitaria Policlinico - Recruiting 18 years or older.
- Residual Vein Thrombosis Establishes the Optimal Duration of Low Molecular Weight Heparins in Cancer Patients With Deep Vein Thrombosis of the Lower Limbs.
low molecular weight heparin